Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15774 articles
Exploring the association between use of gonadotropin releasing hormones agonists and prostate cancer diagnosis per se and diabetes control in men with type 2 diabetes mellitus: a nationwide, population-based cohort study
Diabetes control worse in men with GnRH vs. PCa-free men.
»
11/22/21
The association of aspirin use with overall survival of patients with inoperable non-small cell lung cancer: a retrospective study
Aspirin users had significantly longer OS than non-aspirin users.
»
11/22/21
Prognostic significance of pretreatment serum free fatty acid in patients with diffuse large B-cell lymphoma in the rituximab era: a retrospective analysis
Higher serum FFA levels independent prognostic factors for poor OS.
»
11/21/21
Quantitative multiparametric MRI predicts response to neoadjuvant therapy in the community setting
Patients achieving a pCR had larger decline in volume and cellularity.
»
11/27/21
Downregulation of miR-29c promotes muscle wasting by modulating the activity of leukemia inhibitory factor in lung cancer cachexia
Overexpression of miR-29c mitigated cachectic phenotype.
»
11/27/21
Let-7a induces metabolic reprogramming in breast cancer cells via targeting mitochondrial encoded ND4
Role of mitomiR (let-7a) in regulating mitochondrial genome.
»
11/27/21
Inhibition of XPO1 sensitizes small cell lung cancer to first- and second-line chemotherapy.
Data identify exportin-1 as promising therapeutic target.
»
11/18/21
Inhibition of ERK5 elicits cellular senescence in melanoma via the cyclin-dependent kinase inhibitor p21.
Knockdown of p21 suppressed the induction of cellular senescence by ERK5 blockade.
»
11/15/21
Overall and progression-free survival of Afro-Caribbean men with metastatic castration-resistant prostate cancer (mCRPC).
Men with mCRPC who received hormonotherapy (abiraterone or enzalutamide) showed better progression-free survival .
»
10/19/21
Changes in the Proportion of Patients Presenting with Early Stage Colon Cancer over Time Among Medicaid Expansion and Non-expansion States: A Cross-Sectional Study.
Proportion of patients with early stage within non-expansion states declined by 0.8% per year after 2014.
»
11/22/21
< Prev
Next >